Annual report
7747.TEDINET S100WQNM
Period2024-07-01 → 2025-06-30
Filed2025-09-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥120.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥107.5bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥90.1bn | 2022-07-01 → 2023-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥77.7bn | 2021-07-01 → 2022-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.5bn | 2020-07-01 → 2021-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥30.1bn | 2024-07-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥22.1bn | 2023-07-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥29.6bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥22.0bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥17.6bn | 2022-07-01 → 2023-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.3bn | 2021-07-01 → 2022-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.2bn | 2020-07-01 → 2021-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥18.7bn | 2024-07-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥21.8bn | 2023-07-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.7bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.8bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥13.1bn | 2022-07-01 → 2023-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.9bn | 2021-07-01 → 2022-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.0bn | 2020-07-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥12.8bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥15.9bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥193.2bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥191.6bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥172.6bn | at 2023-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥155.1bn | at 2022-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥115.4bn | at 2021-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥41.8bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥39.7bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥151.4bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥152.0bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥134.3bn | at 2023-06-30v | Cons. | Net assets |
| Net assets / equity | ¥121.1bn | at 2022-06-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥92.9bn | at 2021-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥54.2bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥35.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥53.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2023-06-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.3bn | at 2022-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥21.4bn | at 2021-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥40.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥19.1bn | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥17.3bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.9bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥13.4bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥21.2bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.1bn | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥18.7bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16.3bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥8.1bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥13.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.3bn | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥11.4bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥10.1bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥46.92 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.2 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.25 | 2022-07-01 → 2023-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.01 | 2021-07-01 → 2022-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.25 | 2020-07-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2021-07-01 → 2022-06-30v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.07 | 2020-07-01 → 2021-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥558.31 | at 2025-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥556.71 | at 2024-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥487.12 | at 2023-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥439.8 | at 2022-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥349.18 | at 2021-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 77.9% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.6% | at 2023-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2022-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2021-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.4% | 2024-07-01 → 2025-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2023-07-01 → 2024-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2022-07-01 → 2023-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2021-07-01 → 2022-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2020-07-01 → 2021-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 9,473 | at 2025-06-30 | Cons. | Number of employees |
| Employees | 9,371 | at 2024-06-30 | Cons. | Number of employees |
| Employees | 10,187 | at 2023-06-30v | Cons. | Number of employees |
| Employees | 10,435 | at 2022-06-30v | Cons. | Number of employees |
| Employees | 9,409 | at 2021-06-30d | Cons. | Number of employees |
| Revenue | ¥86.5bn | 2024-07-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥73.8bn | 2023-07-01 → 2024-06-30 | Standalone | Net sales |
| Revenue | ¥63.7bn | 2022-07-01 → 2023-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥63.5bn | 2021-07-01 → 2022-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥50.9bn | 2020-07-01 → 2021-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥21.5bn | 2024-07-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | ¥13.8bn | 2023-07-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | ¥36.7bn | 2024-07-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥13.9bn | 2023-07-01 → 2024-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥12.3bn | 2022-07-01 → 2023-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.2bn | 2021-07-01 → 2022-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.9bn | 2020-07-01 → 2021-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥28.4bn | 2024-07-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥13.7bn | 2023-07-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | ¥21.7bn | 2024-07-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | ¥10.9bn | 2023-07-01 → 2024-06-30 | Standalone | Profit loss |
| Net income | ¥7.2bn | 2022-07-01 → 2023-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥9.5bn | 2021-07-01 → 2022-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.7bn | 2020-07-01 → 2021-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥155.3bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥139.1bn | at 2024-06-30 | Standalone | Assets |
| Total assets | ¥127.3bn | at 2023-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥120.9bn | at 2022-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥91.4bn | at 2021-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥46.5bn | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥41.3bn | at 2024-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥108.8bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥97.8bn | at 2024-06-30 | Standalone | Net assets |
| Net assets / equity | ¥90.2bn | at 2023-06-30v | Standalone | Net assets |
| Net assets / equity | ¥86.2bn | at 2022-06-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥67.2bn | at 2021-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥37.2bn | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥16.7bn | at 2024-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥79.79 | 2024-07-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.11 | 2023-07-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.61 | 2022-07-01 → 2023-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.09 | 2021-07-01 → 2022-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.8 | 2020-07-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.08 | 2021-07-01 → 2022-06-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.68 | 2020-07-01 → 2021-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥24.23 | 2024-07-01 → 2025-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20.37 | 2023-07-01 → 2024-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14.48 | 2022-07-01 → 2023-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11.99 | 2021-07-01 → 2022-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11.26 | 2020-07-01 → 2021-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥403.61 | at 2025-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥360.2 | at 2024-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥332.15 | at 2023-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥317.39 | at 2022-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥252.48 | at 2021-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.1% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.3% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.9% | at 2023-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.3% | at 2022-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2021-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.0% | 2024-07-01 → 2025-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2023-07-01 → 2024-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2022-07-01 → 2023-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2021-07-01 → 2022-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2020-07-01 → 2021-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 271,633,600 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 271,633,600 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 271,633,600 | at 2023-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 271,633,600 | at 2022-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 265,972,800 | at 2021-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,196 | at 2025-06-30 | Standalone | Number of employees |
| Employees | 1,088 | at 2024-06-30 | Standalone | Number of employees |
| Employees | 1,016 | at 2023-06-30v | Standalone | Number of employees |
| Employees | 1,041 | at 2022-06-30v | Standalone | Number of employees |
| Employees | 925 | at 2021-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-07-01 → 2025-06-30 | ¥1.3bn |
| Reconciling Itemsreconciling | depreciation | 2024-07-01 → 2025-06-30 | ¥572m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2025-06-30 | −¥14.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2025-06-30 | −¥14.2bn |
| Reconciling Itemsreconciling | segment assets | at 2025-06-30 | ¥30.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2025-06-30 | −¥8.0bn |
| Devicereportable segment | capex | 2024-07-01 → 2025-06-30 | ¥4.2bn |
| Devicereportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥3.4bn |
| Devicereportable segment | employees | at 2025-06-30 | 3171 pure |
| Devicereportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥26.4bn |
| Devicereportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥12.2bn |
| Devicereportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥14.2bn |
| Devicereportable segment | segment assets | at 2025-06-30 | ¥49.6bn |
| Devicereportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥4.6bn |
| Medicalreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥2.9bn |
| Medicalreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥5.2bn |
| Medicalreportable segment | employees | at 2025-06-30 | 5778 pure |
| Medicalreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥107.8bn |
| Medicalreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥107.8bn |
| Medicalreportable segment | segment assets | at 2025-06-30 | ¥113.1bn |
| Medicalreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥33.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-07-01 → 2025-06-30 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-07-01 → 2025-06-30 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2025-06-30 | ¥134.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2025-06-30 | ¥120.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥14.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-06-30 | ¥162.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2025-06-30 | ¥38.1bn |
| Reconciling Itemsreconciling | capex | 2023-07-01 → 2024-06-30 | ¥904m |
| Reconciling Itemsreconciling | depreciation | 2023-07-01 → 2024-06-30 | ¥481m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2024-06-30 | −¥14.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2024-06-30 | −¥14.3bn |
| Reconciling Itemsreconciling | segment assets | at 2024-06-30 | ¥28.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2024-06-30 | −¥7.6bn |
| Devicereportable segment | capex | 2023-07-01 → 2024-06-30 | ¥5.6bn |
| Devicereportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥3.3bn |
| Devicereportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥26.1bn |
| Devicereportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥11.9bn |
| Devicereportable segment | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥14.3bn |
| Devicereportable segment | segment assets | at 2024-06-30 | ¥46.0bn |
| Devicereportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥5.3bn |
| Medicalreportable segment | capex | 2023-07-01 → 2024-06-30 | ¥6.1bn |
| Medicalreportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥4.7bn |
| Medicalreportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥95.7bn |
| Medicalreportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥95.7bn |
| Medicalreportable segment | segment assets | at 2024-06-30 | ¥117.1bn |
| Medicalreportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥24.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-07-01 → 2024-06-30 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-07-01 → 2024-06-30 | ¥8.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2024-06-30 | ¥121.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2024-06-30 | ¥107.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥14.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-06-30 | ¥163.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2024-06-30 | ¥29.7bn |
| Devicereportable segment | employees | at 2025-06-30 | 342 pure |
| Medicalreportable segment | employees | at 2025-06-30 | 715 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,695
| Item | Context | Value | Unit |
|---|---|---|---|
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior2YearDuration_ConsolidatedAccountingGroupMember | 46929 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior1YearDuration_ConsolidatedAccountingGroupMember | 48009 | |
| Gross scope1 and2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior2YearDuration_ConsolidatedAccountingGroupMember | 49296 | |
| Gross scope1 and2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior1YearDuration_ConsolidatedAccountingGroupMember | 50499 | |
| Gross scope3 greenhouse gas emissions | Prior1YearDuration | 140915 | |
| Gross scope3 greenhouse gas emissions | CurrentYearDuration | 172463 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 74.8 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | － | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 33.5 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 30 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 14.3 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 13 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 29.1 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 25 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row5Member | 20.5 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row5Member | 20 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row6Member | 62.2 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row6Member | － | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row7Member | 80.1 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row7Member | － | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row8Member | 90.0 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row8Member | － | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row9Member | 68.0 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row9Member | 50 | |
| Research and development expenses research and development activities | CurrentYearDuration | 12248000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 10262000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 1985000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 8447000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 2927000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 4232000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 1288000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 271633600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 271633600 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 271633600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 271633600 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 43 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 39 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 161 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 436 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 43 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 15431 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 16153 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 731518 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 123468 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 528796 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 1048831 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 172 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |